Aflac (AFL) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

01.05.25 00:00 Uhr

Werte in diesem Artikel
Aktien

94,88 EUR -0,02 EUR -0,02%

Indizes

5.569,1 PKT 8,2 PKT 0,15%

For the quarter ended March 2025, Aflac (AFL) reported revenue of $4.32 billion, down 20.5% over the same period last year. EPS came in at $1.66, compared to $1.66 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $4.38 billion, representing a surprise of -1.26%. The company delivered an EPS surprise of -1.19%, with the consensus EPS estimate being $1.68.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how Aflac performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Tot. Ben. /Premium - Aflac U.S. 47.7% versus the three-analyst average estimate of 48.3%. Tot. Adj. Expenses/Total Adj. Rev. - Aflac Japan: 19.6% versus the three-analyst average estimate of 19.9%. Tot. Ben. /Premium - Aflac Japan: 65.8% versus 67.3% estimated by three analysts on average. Tot. Adj. Expenses/Total Adj. Rev. - Aflac U.S. 37.6% compared to the 38.5% average estimate based on three analysts. Total adjusted revenues- Aflac Japan: $2.27 billion compared to the $2.40 billion average estimate based on three analysts. The reported number represents a change of -8.1% year over year. Total adjusted revenues- Aflac Japan- Total net earned premiums: $1.68 billion compared to the $1.73 billion average estimate based on three analysts. The reported number represents a change of -7.4% year over year. Total adjusted revenues- Aflac Japan- Net investment income: $593 million versus the three-analyst average estimate of $668.36 million. The reported number represents a year-over-year change of -9.5%. Total adjusted revenues- Aflac U.S.- Other income: $17 million versus $23.33 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a -5.6% change. Revenues- Total net earned premiums: $3.38 billion versus the five-analyst average estimate of $3.37 billion. The reported number represents a year-over-year change of -2.2%. Revenues- Net investment income: $955 million compared to the $936.61 million average estimate based on five analysts. The reported number represents a change of -4.5% year over year. Revenues- Other income (loss): $25 million compared to the $35.69 million average estimate based on five analysts. The reported number represents a change of -13.8% year over year. Total adjusted revenues- Corporate and other: $326 million versus the two-analyst average estimate of $295.98 million. The reported number represents a year-over-year change of +32%. View all Key Company Metrics for Aflac here>>>Shares of Aflac have returned -3.4% over the past month versus the Zacks S&P 500 composite's -0.2% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Only $1 to See All Zacks' Buys and SellsWe're not kidding.Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 256 positions with double- and triple-digit gains in 2024 alone.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Aflac Incorporated (AFL): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Aflac und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf Aflac

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Aflac

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Aflac Inc

Wer­bung

Analysen zu Aflac Inc

DatumRatingAnalyst
21.03.2018Aflac Equal WeightBarclays Capital
03.07.2017Aflac Equal WeightBarclays Capital
01.05.2017Aflac UnderperformRBC Capital Markets
02.02.2017Aflac UnderperformRBC Capital Markets
09.12.2016Aflac UnderperformRBC Capital Markets
DatumRatingAnalyst
16.05.2012Aflac outperformRBC Capital Markets
14.05.2012Aflac overweightBarclays Capital
27.04.2012Aflac sector outperformScotia Capital Markets
26.04.2012Aflac outperformRBC Capital Markets
27.03.2012Aflac overweightBarclays Capital
DatumRatingAnalyst
21.03.2018Aflac Equal WeightBarclays Capital
03.07.2017Aflac Equal WeightBarclays Capital
10.05.2016Aflac Mkt PerformFBR Capital
27.04.2016Aflac NeutralUBS AG
27.04.2016Aflac Sector PerformRBC Capital Markets
DatumRatingAnalyst
01.05.2017Aflac UnderperformRBC Capital Markets
02.02.2017Aflac UnderperformRBC Capital Markets
09.12.2016Aflac UnderperformRBC Capital Markets
09.01.2012Aflac sellUBS AG

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Aflac Inc nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen